352
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Protection of Cone Photoreceptor M-Opsin Degradation with 9-Cis-β-Carotene-Rich Alga Dunaliella bardawil in Rpe65−/− Mouse Retinal Explant Culture

, , , , &
Pages 1221-1231 | Received 08 Aug 2013, Accepted 15 Mar 2014, Published online: 09 Jul 2014
 

Abstract

Purpose: RPE65, a retinal pigment epithelium–specific 65-kDa protein, plays a critical role in the visual cycle of the eye. Rpe65−/− mice develop vision loss due to a lack of 11-cis-retinal, degradation of M-opsin and mislocalization of S-opsin. Several studies have suggested that 9-cis-β-carotene, a precursor of 9-cis-retinal and all-trans-retinal, could have therapeutic applications in vision loss. We therefore examined whether Dunaliella bardawil, a 9-cis-β-carotene-rich alga, protects against the degradation of M-opsin using Rpe65−/− mouse retinal explant cultures.

Methods: The eyes of three-week-old Rpe65−/− and C57BL/6 J mice were enucleated, and the corneas were removed. The eyecups were incubated with culture medium in the absence or presence of D. bardawil for 6 h to 4 days. Localizations of M-opsin proteins in the retina were observed immunohistochemically. Expression levels of M-opsin, S-opsin and rhodopsin proteins were evaluated by Western blot analysis.

Results: In C57BL/6 J mouse retina, no change was observed in localization and expression levels of M-opsin in the explant culture system. In Rpe65−/− mouse retina, the amount of M-opsin protein was decreased in the photoreceptor outer segment after 6 h to 4 days of culture. However, the presence of D. bardawil significantly ameliorated this decrease. In contrast, expression levels of S-opsin and rhodopsin were unchanged in the presence of the explant culture.

Conclusions: These results demonstrate that D. bardawil treatment protects against M-opsin degradation in Rpe65−/− mouse retina and suggest that D. bardawil has therapeutic potential for retinal degeneration caused by Rpe65 gene mutation, such as Leber congenital amaurosis and retinitis pigmentosa.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.